Keywords: Biosimilars, Biological markets, URCH, Forecasts

Biosimilars could account for 2.6% of biological market by 2016, forecasts URCH

Article | 30 March 2010

The value of the biosimilars market segment will account for 2.6% of the biological market by 2016, forecasts a new report from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in